Pharma Pushes For Stronger ‘March In’ Rule Despite Changing Political Dynamics, COVID Complications

 
• By Sarah Karlin-Smith
  
patent license agreement
The Biden administration will have to review more than 80,000 comments on a proposed rule impacting patent rights • Source: Shutterstock

More from Legal & IP

More from Pink Sheet